Market Segmentation:
- By Treatment Type
- Hormonal Therapy
- Non-Hormonal Therapy
- Surgical Treatment
- Others (Pain Management, Complementary Therapies)
- By Route of Administration
- Oral
- Parenteral
- Others (Vaginal, Transdermal)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others (Clinics, Fertility Centers)
- By End-User
- Hospitals
- Gynecology Clinics
- Fertility Centers
- Research Institutes
- Others (Home Care Settings)
- By Age Group
- Below 30 Years
- 30-45 Years
- Above 45 Years
- By Severity
- Minimal
- Mild
- Moderate
- Severe
- By Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Endometriosis industry is approximately USD 1.8 billion.
Increasing prevalence of endometriosis, Rising awareness and diagnosis rates, Development of improved treatment options, Supportive government initiatives, Increasing healthcare expenditure, Favorable reimbursement policies, Growing focus on women's health, Advancements in diagnostic techniques, Increasing adoption of minimally invasive surgeries, Growing demand for personalized medicine.
Lack of definitive cure, High treatment costs, Delayed diagnosis and misdiagnosis, Lack of awareness and understanding, Side effects of existing treatments, Limited access to healthcare facilities in some regions, Stringent regulatory environment.
The leading component segment in the Endometriosis Market is the Hormonal Therapy segment, which includes various hormonal drugs for endometriosis treatment.
AbbVie, Bayer AG, Pfizer, Myovant Sciences, ObsEva SA, Ferring Pharmaceuticals, Takeda Pharmaceutical, Astellas Pharma, Kissei Pharmaceutical, Shionogi.
The Global Endometriosis Market is expected to reach US$ 3.8 Billion in 2031, registering a CAGR of 9.8% during the forecast period of 2024-2031.
Increasing prevalence of endometriosis, Rising awareness and diagnosis rates, Development of improved treatment options, Supportive government initiatives, Increasing healthcare expenditure, Growing demand for personalized medicine, Advancements in diagnostic techniques, Increasing adoption of minimally invasive surgeries.